Initial Management of Diabetes
The initial management of diabetes should include lifestyle modifications, diabetes self-management education and support (DSMES), and appropriate pharmacological therapy, with metformin as the first-line medication for type 2 diabetes and insulin for type 1 diabetes or severely symptomatic type 2 diabetes. 1, 2
Diagnosis and Classification
Before initiating treatment, proper classification of diabetes is essential:
- Type 1 diabetes: Characterized by autoimmune destruction of pancreatic β-cells, requires insulin therapy
- Type 2 diabetes: Characterized by progressive insulin secretory defect on the background of insulin resistance
- Other specific types: Including genetic defects, diseases of the exocrine pancreas, etc.
- Gestational diabetes: Diagnosed during pregnancy
Diagnostic criteria:
- Fasting plasma glucose ≥126 mg/dL, or
- 2-hour plasma glucose ≥200 mg/dL during OGTT, or
- HbA1C ≥6.5%, or
- Random plasma glucose ≥200 mg/dL with symptoms of hyperglycemia
Comprehensive Care Team Approach
A physician-coordinated team approach is essential for optimal diabetes management 1, 2:
- Physicians
- Nurse practitioners/physician assistants
- Diabetes educators
- Registered dietitians
- Pharmacists
- Mental health professionals
Initial Management Steps
1. Lifestyle Management
Lifestyle interventions form the foundation of diabetes care 1, 2:
Medical Nutrition Therapy:
- Individualized approach based on patient preferences and metabolic goals
- DASH-style eating pattern with reduced sodium and increased potassium intake
- Focus on portion control and healthy food choices rather than specific macronutrient percentages
Physical Activity:
- At least 150 minutes per week of moderate-intensity aerobic activity
- Resistance training 2-3 times per week
- Break up prolonged sitting every 30 minutes
Weight Management:
- For overweight/obese patients, aim for 5-10% weight loss
- Consider referral to intensive lifestyle intervention programs
Smoking Cessation:
- Advise all patients not to use cigarettes and other tobacco products
2. Diabetes Self-Management Education and Support (DSMES)
DSMES is a critical element of care for all people with diabetes 1:
Should be provided at four critical times:
- At diagnosis
- Annually
- When complicating factors arise
- During transitions in care
Key components:
- Diabetes pathophysiology and treatment options
- Medication usage
- Monitoring blood glucose
- Preventing, detecting, and treating acute and chronic complications
- Healthy coping with psychosocial issues and concerns
- Problem-solving and addressing barriers
3. Pharmacological Therapy
For Type 2 Diabetes:
First-line therapy: Metformin (unless contraindicated) 2, 3, 4
- Start at low dose (500 mg daily or twice daily)
- Gradually titrate to effective dose (typically 2000 mg/day)
- Monitor for GI side effects and vitamin B12 deficiency
If HbA1C targets not met with metformin alone:
- For patients with established ASCVD, heart failure, or CKD: Add SGLT2 inhibitor or GLP-1 receptor agonist with proven cardiovascular benefit 1, 2
- For patients with obesity: Consider GLP-1 receptor agonist or dual GIP/GLP-1 receptor agonist 2, 4
- Other options include DPP-4 inhibitors, sulfonylureas, thiazolidinediones 5, or basal insulin
For Type 1 Diabetes:
- Insulin therapy: Multiple daily injections or insulin pump therapy
- Education on carbohydrate counting and insulin dose adjustment
For Severely Symptomatic Type 2 Diabetes (HbA1C ≥8.5%):
- Insulin therapy: May be needed initially, with potential de-escalation once glucose levels improve 2
Monitoring and Follow-up
- Self-monitoring of blood glucose: Frequency depends on medication regimen and glycemic targets
- HbA1C monitoring: Every 3 months until target reached, then at least twice yearly
- Regular assessment of complications:
- Cardiovascular risk factors
- Kidney function
- Retinopathy
- Neuropathy
- Foot health
Addressing Cardiovascular Risk
Hypertension management 1:
- Target blood pressure <130/80 mmHg
- First-line agents: ACE inhibitors, ARBs, thiazide-like diuretics, or dihydropyridine calcium channel blockers
- For patients with albuminuria: ACE inhibitors or ARBs
Lipid management:
- Most adults with diabetes aged ≥40 years should be on moderate-intensity statin therapy
Common Pitfalls and Caveats
- Delayed intensification: Don't delay treatment intensification when targets are not met
- Hypoglycemia risk: Consider risk factors when selecting therapy, particularly in elderly patients
- Medication adherence: Address barriers including cost, side effects, and complexity
- Overemphasis on glycemic control alone: Remember to address all cardiovascular risk factors
- Neglecting psychological aspects: Screen for diabetes distress and depression
- Failure to individualize targets: Consider age, comorbidities, and hypoglycemia risk when setting goals
By implementing these initial management steps comprehensively, healthcare providers can help patients achieve better glycemic control and reduce the risk of diabetes-related complications, ultimately improving morbidity, mortality, and quality of life outcomes.